- Appoints seasoned medical device executive, Jodie Fam, as Chief Executive Officer
- Transition strategically positions company for next stage of
growth
FREMONT,
Calif., July 22, 2024 /PRNewswire/ -- Q'Apel
Medical (Q'Apel), a private medical device company focused on
revolutionizing neurovascular interventions, announced today the
appointment of Jodie Fam as Chief
Executive Officer. With over two decades in the medical device
industry, Jodie has held executive leadership positions at multiple
medical device companies including public and several
venture-backed start-ups. During her industry tenure she has built
a solid track record of experience in execution and commercial
expansion. She succeeds R. King
Nelson, who retires after leading the company for the last
five years and will continue to serve on Q'Apel's Board of
Directors.
"Together, we will build upon our strong
foundation to position Q'Apel for a new era of growth, stability
and success."
"On behalf of the Board, we thank King for his leadership. He
has built a strong team and delivered significant growth for the
company," said Chris Martin,
Chairman of Q'Apel's Board. "We are pleased to have Jodie assume
this role and are confident that with her at the helm, Q'Apel is
positioned for an incredibly bright future."
"Jodie has been an integral part of Q'Apel's leadership team for
the past three years as Chief Marketing Officer and General Manager
of International. We are thrilled to have her lead the organization
going forward," commented Mr. Nelson. "With a deep industry
knowledge and expertise bringing disruptive technologies to market,
Jodie is ideally suited to spearhead this next phase of the
company's growth. I am confident that under her leadership, the
organization will deliver on its strategic objectives and drive
commercial value."
Most recently, Jodie served as Q'Apel's Chief Marketing Officer
and General Manager for the company's international business. Prior
to joining Q'Apel, she served as the CEO of AblaCare (now May
Health) and held senior management positions at Route 92 Medical,
Medina Medical (acquired by Medtronic), CardioKinetix and
Concentric Medical (acquired by Stryker). Earlier in her career,
Jodie held senior clinical, sales and marketing positions with
Guidant Corporation, Johnson & Johnson and Mallinckrodt
Medical.
"Since its inception, Q'Apel has been known for approaching
clinical challenges differently. It is at the core of all we do and
one of the most differentiating aspects of our organization,"
stated Jodie Fam. "I am thrilled and
honored to serve as the company's next CEO and look forward to
working with our world-class team. Together, we will build upon our
strong foundation to uniquely and purposefully position Q'Apel for
a new era of growth, stability and success."
About Q'Apel Medical:
Q'Apel Medical is revolutionizing neurovascular interventions.
Inspired by the evolving needs of our customers, our novel approach
allows us to solve clinical challenges where others fall short. We
are up for the task, the more complex the better. Our team thrives
on creating high quality uniquely engineered products, designed in
partnership with neurovascular specialists, that address what is
needed right now, yet with the versatility to focus on what is
coming next. For more information, visit www.qapelmedical.com.
Media Contact:
Charlene
Herndon
SPRIG Consulting
charlene@sprigconsulting.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/qapel-medical-announces-leadership-transition-302202641.html
SOURCE Q'Apel Medical Inc.